Journal Article DKFZ-2026-00009

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Distribution and prognostic value of T-cells in primary colorectal cancer and adjacent non-tumor mucosa in stage IV versus stage I-III patients.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
Wiley-Liss Bognor Regis

International journal of cancer 158(10), 2760-2770 () [10.1002/ijc.70319]
 GO

Abstract: Analyzing T-cell subsets in and between primary colorectal cancer (pCRC) and adjacent non-tumor mucosa (NM) may reveal distinct prognostic value in stage IV versus stages I-III patients. Specimens of pCRC and NM were collected retrospectively from stage IV patients (n = 55) with synchronous liver metastases (LM), and stages I-III patients (n = 44) who developed metachronous LM. CD3+, CD8+, CD45RO+, CD4+, and Foxp3+ T-cells were quantified in NM and the tumor center (TC) of pCRC using immunohistochemistry. T-cell densities in NM and TC and their ratios (TC/NM) were tested as prognostic variables for overall survival (OS), along with Foxp3+/CD8+, Foxp3+/CD4+ and CD4+/CD8+ ratios. In stages I-III, associations with the time to occurrence of LM were also evaluated. In both groups, NM exhibited greater densities of CD3+, CD8+, CD45RO+, and CD4+ cells compared to TC, whereas Foxp3+ cells were more abundant in the TC. In stage IV, high densities of Foxp3+ cells, high Foxp3+/CD4+ and Foxp3+/CD8+ ratios in the NM, and high CD4+ cell densities in the TC were associated with longer OS. Stages I-III patients with a high CD4+/CD8+ ratio in the NM had longer OS, whereas a high Foxp3+/CD8+ ratio in the TC was associated with a shorter time to LM. We revealed a significant difference in the T-cell landscape between pCRC and adjacent NM with Foxp3+ cells predominating in the TC and other subsets in the NM. Assessing T-cells and their ratios in both regions may improve prediction of survival in CRC patients and the time to LM in stages I-III.

Keyword(s): T‐cells ; adjacent non‐tumor mucosa ; liver metastases ; primary colorectal cancer ; survival

Classification:

Note: 2026 May 15;158(10):2760-2770

Contributing Institute(s):
  1. Epidemiologie von Krebs (C020)
  2. Erimitus im DKFZ (Z999)
Research Program(s):
  1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2025
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Wiley ; Essential Science Indicators ; IF >= 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > C020
Public records
Publications database

 Record created 2026-01-05, last modified 2026-03-19



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)